Business Description
Neuroscientific Biopharmaceuticals Ltd
Compare
Compare
Traded in other countries / regions
NSB.Australia IPO Date
2018-06-27Description
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.9 | |||||
| 3-Year EPS without NRI Growth Rate | -47 | |||||
| 3-Year FCF Growth Rate | -33.9 | |||||
| 3-Year Book Growth Rate | -18 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.35 | |||||
| 9-Day RSI | 32.6 | |||||
| 14-Day RSI | 34.79 | |||||
| 6-1 Month Momentum % | 1.11 | |||||
| 12-1 Month Momentum % | -68.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.21 | |||||
| Quick Ratio | 3.21 | |||||
| Cash Ratio | 3.04 | |||||
| Days Sales Outstanding | 24.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -677.31 | |||||
| Net Margin % | -669.89 | |||||
| ROE % | -128.76 | |||||
| ROA % | -107.72 | |||||
| ROIC % | -2004.26 | |||||
| ROC (Joel Greenblatt) % | -44433.96 | |||||
| ROCE % | -130.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.62 | |||||
| PB Ratio | 4.48 | |||||
| Price-to-Tangible-Book | 4.25 | |||||
| EV-to-EBIT | -1.14 | |||||
| EV-to-EBITDA | -1.14 | |||||
| EV-to-Revenue | 7.66 | |||||
| EV-to-FCF | -1.46 | |||||
| Price-to-Net-Current-Asset-Value | 4.25 | |||||
| Price-to-Net-Cash | 4.25 | |||||
| Earnings Yield (Greenblatt) % | -88.37 |
How Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1.159 | ||
| EPS (TTM) (A$) | -0.054 | ||
| Beta | 0.09 | ||
| Volatility % | 84.52 | ||
| 14-Day RSI | 34.79 | ||
| 14-Day ATR (A$) | 0.002265 | ||
| 20-Day SMA (A$) | 0.0914 | ||
| 12-1 Month Momentum % | -68.07 | ||
| 52-Week Range (A$) | 0.07 - 0.31 | ||
| Shares Outstanding (Mil) | 143.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neuroscientific Biopharmaceuticals Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neuroscientific Biopharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neuroscientific Biopharmaceuticals Ltd Frequently Asked Questions
What is Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)'s stock price today?
The current price of ASX:NSB is A$0.09. The 52 week high of ASX:NSB is A$0.31 and 52 week low is A$0.07.
When is next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)?
The next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) is .
Does Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) pay dividends? If so, how much?
Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
